Nonetheless, our data points to the fact that ACAT-1 expression is greater in MDA-MB-231 cells chronically exposed to CDDP (MDACR), which might reflect events that occur in response to anti-cancer treatments. This evidence concerns the gene ACAT1 and cancer.